AGP Executive Report
Last update: 6 hours agoPrescription CBD: Kazmira Therapeutics is partnering with CareValidate to offer THC-free, prescription CBD through telehealth and licensed pharmacies. The company says federal hemp restrictions taking effect in December could push many current retail CBD products outside the legal definition of hemp. Insomnia Research: A review of nine trials found medical cannabis offered little or no meaningful improvement in adults’ sleep, with uncertain evidence and slightly more adverse events than placebo. Prescribing Safety: A Jersey coroner urged officials to consider pausing new medical cannabis prescriptions for mental-health conditions after finding cannabis contributed to a man’s mental-health decline before his death. Pain Research: A small study cited in a consumer health column found topical CBD gel improved arthritis symptoms compared with placebo, but larger studies are needed.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
